Stay updated on Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.
Latest updates to the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page
- Check5 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check12 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for inquiries about joining the study and includes a reference to the Contacts and Locations section in the How to Read a Study Record.SummaryDifference0.8%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNew dates have been added for November 2024, while several links related to ovarian cancer and clinical trials have been removed, indicating a potential shift in focus or content availability.SummaryDifference2%
- Check34 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new resources added related to ovarian cancer, clinical trials, and treatment options, while the previous version 2.12.1 has been removed.SummaryDifference2%
- Check48 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.1, indicating a new release with potential improvements or features.SummaryDifference0.1%
- Check80 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.0%
Stay in the know with updates to Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Chemo, Olaparib Maint in EOC Clinical Trial page.